Nicholas Meadows is a highly experienced professional with over 12 years in the Life Sciences industry, specializing in Corporate Strategy, Biosimilars Development, and Commercial Strategy.

His background includes roles as a Strategy Consultant, Technology Transfer analyst, and post-doctoral scientist, providing him with a unique blend of technical expertise and strategic acumen.

Nicholas has been involved in various engagements such as developing growth strategies for Pharma, Medtech, Wholesale and Distribution sectors, as well as overseeing regulatory aspects in multi-billion dollar asset swap deals.

He holds an MBA from the University of Oxford - Said Business School and a PhD in Molecular Biology from the University of Queensland.

Currently, Nicholas serves as a Director at Strategy& and has held key positions at notable organizations like Kinapse and Isis Innovation Ltd.

His specialties include Organisation Design, Stratified Medicine, Market Access, Change Management, and Translational Research, showcasing his diverse skill set within the Life Sciences field.